Raju Prasad, CFO: Crispr Therapeutics CRSP Sell · Filed 25/03/18

Trade details

Type: Insider sale
Amount: $157,251.6
Shares · price: 3,762 sh · $41.80 a share
Held after: 12,714 sh
Stock: Crispr Therapeutics CRSP
Person: Raju PrasadCFO
Trade date: 25/03/17
Filed: 25/03/18
Days to filing: 1 days

Sold 22.8% of holdings

Share of holding sold: 22.8%

Crispr Therapeutics trades, last 26 weeks

What else happened in Crispr Therapeutics around then

Filed or reported within 30 days of the trade day · 25/02/15~25/04/16

Raju Prasad's recent trades

Raju PrasadCFO
SellCrispr Therapeutics
Sell
Crispr Therapeutics
CRSP
$173.5K
3,708 sh
$173.5K
Filed 03/24
Traded 03/23
Raju PrasadCFO
SellCrispr Therapeutics
Sell
Crispr Therapeutics
CRSP
$282.2K
5,848 sh
$282.2K
Filed 03/17
Traded 03/16
Raju PrasadCFO
SellCrispr Therapeutics
Sell
Crispr Therapeutics
CRSP
$194.1K
4,021 sh
$194.1K
Filed 03/17
Traded 03/16
Raju PrasadCFO
Sell10b5-1 planCrispr Therapeutics
Sell10b5-1 plan
Crispr Therapeutics
CRSP
$2.1M
34,972 sh
$2.1M
Filed 01/26
Traded 01/22
Raju PrasadCFO
Planned sale10b5-1 planCrispr Therapeutics
Planned sale10b5-1 plan
Crispr Therapeutics
CRSP
$2.1M
34,972 sh
$2.1M
Filed 01/22
Traded 01/22

Raju Prasad, CFO — sold $157.3K of Crispr Therapeutics CRSP · 22.8% of holdings | Whalegun